{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:59:38Z","timestamp":1791417578796,"version":"4.3.3"},"reference-count":171,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CIHR and the Natural Sciences and Engineering Research Council of Canada"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DA022340"],"award-info":[{"award-number":["DA022340"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neubiorev.2016.12.033","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T13:34:45Z","timestamp":1492781685000},"page":"56-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":206,"special_numbering":"PA","title":["The endocannabinoid system as a target for novel anxiolytic drugs"],"prefix":"10.1016","volume":"76","author":[{"given":"Sachin","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew N.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Cheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten T.","family":"Wotjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2016.12.033_bib0005","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.neubiorev.2014.03.026","article-title":"Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels","volume":"46","author":"Aguiar","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0010","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/FBP.0b013e3283564dfa","article-title":"The temporal dynamics of the effects of monoacylglycerol lipase blockade on locomotion, anxiety, and body temperature","volume":"23","author":"Aliczki","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0015","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.yhbeh.2013.03.017","article-title":"Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice","volume":"63","author":"Aliczki","year":"2013","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0020","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.pbb.2013.02.012","article-title":"Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats","volume":"105","author":"Almeida-Santos","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0025","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/hipo.20946","article-title":"The use of knockout mice to test the specificity of antibodies for cannabinoid receptors","volume":"22","author":"Ashton","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0030","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pnpbp.2011.12.001","article-title":"CB(2): therapeutic target-in-waiting","volume":"38","author":"Atwood","year":"2012","journal-title":"Progress in Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0035","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneumeth.2013.03.021","article-title":"Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB(2) receptor","volume":"216","author":"Baek","year":"2013","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0040","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0045","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0050","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0055","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1038\/tp.2014.53","article-title":"Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation","volume":"4","author":"Bluett","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0060","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/jcbfm.2015.119","article-title":"The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [11C]CURB","volume":"35","author":"Boileau","year":"2015","journal-title":"J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0065","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/jts.20243","article-title":"Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users","volume":"20","author":"Bonn-Miller","year":"2007","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0070","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00213-015-4105-9","article-title":"Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?","volume":"233","author":"Boorman","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0075","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.celrep.2016.06.082","article-title":"Endocannabinoid-Mediated plasticity in nucleus accumbens controls vulnerability to anxiety after social defeat stress","volume":"16","author":"Bosch-Bouju","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0080","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1176\/ajp.153.3.369","article-title":"Chronic PTSD in Vietnam combat veterans: course of illness and substance abuse","volume":"153","author":"Bremner","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0085","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","volume":"70","author":"Busquets-Garcia","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0090","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/bies.201500046","article-title":"Dissecting the cannabinergic control of behavior: the where matters","volume":"37","author":"Busquets-Garcia","year":"2015","journal-title":"BioEssays: News and Reviews in Molecular, Cellular and Dvelopmental Biology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0095","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0105","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int. J. Neuropsychopharmacol. Off. Sci. J. Collegium Internationale Neuropsychopharmacologicum"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0110","doi-asserted-by":"publisher","first-page":"e0119401","DOI":"10.1371\/journal.pone.0119401","article-title":"Visualization by high resolution immunoelectron microscopy of the transient receptor potential vanilloid-1 at inhibitory synapses of the mouse dentate gyrus","volume":"10","author":"Canduela","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0115","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.euroneuro.2015.07.015","article-title":"Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats","volume":"25","author":"Carnevali","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0120","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0125","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0130","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/npp.2011.207","article-title":"Opposing roles for cannabinoid receptor type-1 (CB(1)) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats","volume":"37","author":"Casarotto","year":"2012","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0135","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1523\/JNEUROSCI.6451-10.2011","article-title":"Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells","volume":"31","author":"Cavanaugh","year":"2011","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0140","series-title":"The Cochrane Database of Systematic Reviews, CD006115","article-title":"Azapirones for generalized anxiety disorder","author":"Chessick","year":"2006"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0145","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/hmg\/ddh216","article-title":"Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use","volume":"13","author":"Chiang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0150","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1037\/a0023076","article-title":"Posttraumatic stress disorder and cannabis use in a nationally representative sample","volume":"25","author":"Cougle","year":"2011","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0155","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0160","doi-asserted-by":"publisher","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0165","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0170","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuroscience.2007.11.047","article-title":"Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain","volume":"151","author":"Cristino","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0175","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"DSM-5","year":"2013"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0180","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.biopsych.2015.12.021","article-title":"Interactions between anandamide and corticotropin-Releasing factor signaling modulate human amygdala function and risk for anxiety disorders: an imaging genetics strategy for modeling molecular interactions","volume":"80","author":"Demers","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0185","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1038\/ncomms7395","article-title":"FAAH genetic variation enhances fronto-amygdala function in mouse and human","volume":"6","author":"Dincheva","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1503\/jpn.160116","article-title":"Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through amygdala long-term depression in male rodents","volume":"42","author":"Duan","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0195","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nchembio.663","article-title":"(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2","volume":"7","author":"Duggan","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0200","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00210-016-1226-6","article-title":"Lack of hippocampal CB1 receptor desensitization by Delta(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184","volume":"389","author":"Feliszek","year":"2016","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0205","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","article-title":"Cannabinoid CB2 receptor: a new target for controlling neural cell survival?","volume":"28","author":"Fernandez-Ruiz","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0210","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","article-title":"Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience","volume":"24","author":"Fogaca","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0215","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1038\/ncomms8118","article-title":"Photoswitchable fatty acids enable optical control of TRPV1","volume":"6","author":"Frank","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0220","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0225","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14137","article-title":"Cyclooxygenase-2 inhibition reduces stress-induced affective pathology","volume":"5","author":"Gamble-George","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0230","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1523\/JNEUROSCI.4671-10.2011","article-title":"Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis","volume":"31","author":"Garami","year":"2011","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0235","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors","volume":"160","author":"Garcia-Gutierrez","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0240","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.neuropharm.2013.05.034","article-title":"Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors","volume":"73","author":"Garcia-Gutierrez","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0245","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1073\/pnas.1600013113","article-title":"Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species","volume":"113","author":"Gee","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0250","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0255","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/0269881110389095","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors","volume":"26","author":"Gomes","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0260","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.euroneuro.2012.09.007","article-title":"Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT(1)A receptor","volume":"23","author":"Gomes","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0265","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","article-title":"Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety","volume":"35","author":"Gray","year":"2015","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0270","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0275","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimaraes","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0280","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1460-9568.2004.03428.x","article-title":"Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala","volume":"20","author":"Gulyas","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0285","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1038\/npp.2015.318","article-title":"Fluoxetine facilitates fear extinction through amygdala endocannabinoids","volume":"41","author":"Gunduz Cinar","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0290","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0295","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/mp.2012.72","article-title":"Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity","volume":"18","author":"Gunduz-Cinar","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0300","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cne.24066","article-title":"Anatomical characterization of the cannabinoid CB1 receptor in cell-type-specific mutant mouse rescue models","volume":"525","author":"Gutierrez-Rodriguez","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0305","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00213-009-1494-7","article-title":"Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats","volume":"204","author":"Haller","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0310","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00213-013-3273-8","article-title":"Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice","volume":"231","author":"Haller","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0315","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cell.2012.01.037","article-title":"Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD","volume":"148","author":"Han","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0320","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2008.10.047","article-title":"Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function","volume":"66","author":"Hariri","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0325","doi-asserted-by":"publisher","first-page":"e749","DOI":"10.1038\/tp.2016.26","article-title":"2-arachidonoylglycerol signaling impairs short-term fear extinction","volume":"6","author":"Hartley","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0330","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1515\/revneuro-2012-0058","article-title":"Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression","volume":"23","author":"Hauer","year":"2012","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0335","doi-asserted-by":"publisher","first-page":"e62741","DOI":"10.1371\/journal.pone.0062741","article-title":"Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder","volume":"8","author":"Hauer","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0340","doi-asserted-by":"publisher","DOI":"10.1038\/nature20127","article-title":"A cannabinoid link between mitochondria and memory","author":"Hebert-Chatelain","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0345","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/nn.3480","article-title":"Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation","volume":"16","author":"Hermanson","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0350","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tips.2014.04.006","article-title":"Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation","volume":"35","author":"Hermanson","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0355","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0360","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00702-008-0131-7","article-title":"Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents","volume":"115","author":"Hill","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0365","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.psyneuen.2009.03.013","article-title":"Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress","volume":"34","author":"Hill","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0370","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","article-title":"Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks","volume":"38","author":"Hill","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0375","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.90","article-title":"Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure","author":"Hill","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0380","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/mt.2013.247","article-title":"Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury","volume":"22","author":"Hirai","year":"2014","journal-title":"Molecular Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0385","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0390","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/nn.4113","article-title":"Neuroimmune mechanisms of depression","volume":"18","author":"Hodes","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0395","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.neubiorev.2008.03.006","article-title":"Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease","volume":"32","author":"Holmes","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0400","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2011.08.013","article-title":"Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats","volume":"62","author":"Hsiao","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0405","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/bjp.2008.33","article-title":"Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity","volume":"153","author":"Hu","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0410","doi-asserted-by":"crossref","first-page":"e5183","DOI":"10.1590\/1414-431x20165183","article-title":"Involvement of the TRPV1 channel in the modulation of spontaneous locomotor activity, physical performance and physical exercise-induced physiological responses","volume":"49","author":"Hudson","year":"2016","journal-title":"Braz. J. Med. Biol. Res. Revista brasileira de pesquisas medicas e biologicas"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0415","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB2 receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0420","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.biopsych.2015.03.033","article-title":"Anxiety, stress, and fear response in mice with reduced endocannabinoid levels","volume":"79","author":"Jenniches","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0425","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0430","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0435","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1073\/pnas.93.6.2317","article-title":"COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex","volume":"93","author":"Kaufmann","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0440","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/j.1476-5381.2010.01157.x","article-title":"Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey","volume":"163","author":"Kawahara","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0445","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the national comorbidity survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0450","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nn1262","article-title":"Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus","volume":"7","author":"Kim","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0455","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1124\/jpet.112.201426","article-title":"Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects","volume":"345","author":"Kinsey","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0460","doi-asserted-by":"publisher","first-page":"33744","DOI":"10.1074\/jbc.M007088200","article-title":"Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2","volume":"275","author":"Kozak","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0465","doi-asserted-by":"publisher","first-page":"44877","DOI":"10.1074\/jbc.M206788200","article-title":"Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides","volume":"277","author":"Kozak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0470","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.156","article-title":"Cannabinoid C receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat","author":"Lange","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0475","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0480","doi-asserted-by":"publisher","first-page":"10039","DOI":"10.1523\/JNEUROSCI.4112-14.2015","article-title":"Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release","volume":"35","author":"Lee","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0485","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/gbb.12253","article-title":"Developmental regulation of fear learning and anxiety behavior by endocannabinoids","volume":"15","author":"Lee","year":"2016","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0490","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/cercor\/bhr220","article-title":"5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons","volume":"22","author":"Llado-Pelfort","year":"2012","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0495","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s00213-015-3917-y","article-title":"2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons","volume":"232","author":"Llorente-Berzal","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0500","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/npp.2014.198","article-title":"Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain","volume":"40","author":"Lomazzo","year":"2015","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0505","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn3229","article-title":"Impaired mitochondrial function in psychiatric disorders","volume":"13","author":"Manji","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0510","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.bbr.2015.02.023","article-title":"Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT(1)A receptors and stressful experiences","volume":"286","author":"Marinho","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0515","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1523\/JNEUROSCI.3303-06.2007","article-title":"Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice","volume":"27","author":"Marsch","year":"2007","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0520","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/bph.12400","article-title":"Towards a better cannabis drug","volume":"170","author":"Mechoulam","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0525","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/npp.2008.98","article-title":"Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels","volume":"34","author":"Micale","year":"2009","journal-title":"Neuropsychopharmacology: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0530","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","article-title":"Endocannabinoid system and mood disorders: priming a target for new therapies","volume":"138","author":"Micale","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0535","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0540","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuroscience.2011.08.046","article-title":"Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?","volume":"204","author":"Moreira","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0545","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuropharm.2016.08.020","article-title":"Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety","volume":"111","author":"Morena","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0550","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0555","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-006-0689-4","article-title":"Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality","volume":"192","author":"Naidu","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0560","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.phrs.2014.04.014","article-title":"The dual blocker of FAAH\/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis","volume":"87","author":"Navarria","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0565","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0570","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1523\/JNEUROSCI.5102-07.2008","article-title":"Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals","volume":"28","author":"Nyilas","year":"2008","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0575","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.tins.2015.07.006","article-title":"Do stars govern our actions? Astrocyte involvement in rodent behavior","volume":"38","author":"Oliveira","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0580","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0585","doi-asserted-by":"publisher","first-page":"e1640","DOI":"10.1371\/journal.pone.0001640","article-title":"Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects","volume":"3","author":"Onaivi","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0590","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0595","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0024-3205(99)00286-6","article-title":"Presence and functional regulation of cannabinoid receptors in immune cells","volume":"65","author":"Parolaro","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0600","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1124\/jpet.106.101287","article-title":"Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling","volume":"318","author":"Patel","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0605","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/sj.npp.1300535","article-title":"Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala","volume":"30","author":"Patel","year":"2005","journal-title":"Neuropsychopharmacology: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0610","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/nn.2974","article-title":"Polymodal activation of the endocannabinoid system in the extended amygdala","volume":"14","author":"Puente","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0615","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00429-014-0711-2","article-title":"The transient receptor potential vanilloid-1 is localized at excitatory synapses in the mouse dentate gyrus","volume":"220","author":"Puente","year":"2015","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0620","doi-asserted-by":"publisher","first-page":"12125","DOI":"10.1523\/JNEUROSCI.3400-08.2008","article-title":"Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain","volume":"28","author":"Racz","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0625","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2007.06.012","article-title":"Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice","volume":"54","author":"Rademacher","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0630","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0635","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0640","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1007\/s00213-015-3939-5","article-title":"Role of CB2 receptors in social and aggressive behavior in male mice","volume":"232","author":"Rodriguez-Arias","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0645","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1177\/0269881113485144","article-title":"Cooperative regulation of anxiety and panic-related defensive behaviors in the rat periaqueductal grey matter by 5-HT1A and mu-receptors","volume":"27","author":"Roncon","year":"2013","journal-title":"J. Psychopharmacol. (Oxford, Engl.)"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0650","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1124\/mol.110.064196","article-title":"Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition","volume":"78","author":"Rossi","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0655","doi-asserted-by":"publisher","first-page":"10264","DOI":"10.1523\/JNEUROSCI.4171-12.2013","article-title":"Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions","volume":"33","author":"Ruehle","year":"2013","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0660","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0665","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.tips.2016.04.005","article-title":"Beyond cannabis: plants and the endocannabinoid system","volume":"37","author":"Russo","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0670","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/syn.21621","article-title":"Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation","volume":"67","author":"Saito","year":"2013","journal-title":"Synapse"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0675","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1113\/jphysiol.2006.105569","article-title":"PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons","volume":"572","author":"Sang","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0680","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/cercor\/bhh070","article-title":"Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex","volume":"14","author":"Santana","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0685","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.expneurol.2009.01.016","article-title":"Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor","volume":"217","author":"Savonenko","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0690","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","article-title":"Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice","volume":"64","author":"Schiavon","year":"2016","journal-title":"Progress in Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0695","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0700","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1124\/jpet.114.212753","article-title":"Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice","volume":"350","author":"Schlosburg","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0705","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.phrs.2011.04.010","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","volume":"64","author":"Sciolino","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0710","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.celrep.2014.11.001","article-title":"Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation","volume":"9","author":"Shonesy","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0715","doi-asserted-by":"publisher","first-page":"8394","DOI":"10.1073\/pnas.082235799","article-title":"A missense mutation in human fatty acid amide hydrolase associated with problem drug use","volume":"99","author":"Sipe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0720","doi-asserted-by":"publisher","first-page":"e8792","DOI":"10.1371\/journal.pone.0008792","article-title":"Biomarkers of endocannabinoid system activation in severe obesity","volume":"5","author":"Sipe","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0725","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.neuropharm.2005.04.019","article-title":"Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus","volume":"49","author":"Slanina","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0730","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/acer.13210","article-title":"FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence","volume":"40","author":"Spagnolo","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0735","doi-asserted-by":"publisher","first-page":"9845","DOI":"10.1002\/anie.201302530","article-title":"Optical control of TRPV1 channels","volume":"52","author":"Stein","year":"2013","journal-title":"Angewandte Chemie"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0740","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neuron.2016.03.034","article-title":"Cannabinoid type 2 receptors mediate a cell type-Specific plasticity in the hippocampus","volume":"90","author":"Stempel","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0745","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0306-4603(98)00070-7","article-title":"Functional associations among trauma, PTSD, and substance-related disorders","volume":"23","author":"Stewart","year":"1998","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0750","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1038\/npp.2011.166","article-title":"Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation","volume":"36","author":"Sumislawski","year":"2011","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0755","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1016\/j.febslet.2011.06.004","article-title":"Central PGE2 exhibits anxiolytic-like activity via EP1 and EP4 receptors in a manner dependent on serotonin 5-HT1A, dopamine D1 and GABAA receptors","volume":"585","author":"Suzuki","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0760","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.euroneuro.2008.11.004","article-title":"Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray","volume":"19","author":"Terzian","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0765","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/(SICI)1097-4547(19971215)50:6<1047::AID-JNR16>3.0.CO;2-1","article-title":"Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system","volume":"50","author":"Thomas","year":"1997","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0770","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0304-3940(98)00700-9","article-title":"Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry","volume":"254","author":"Tsou","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0775","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuropharm.2015.12.020","article-title":"Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning","volume":"103","author":"Uliana","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0780","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bbalip.2014.12.015","article-title":"Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases","volume":"1851","author":"Urquhart","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0785","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.neuropharm.2011.01.027","article-title":"Enhancement of apamin-sensitive medium afterhyperpolarization current by anandamide and its role in excitability control in cultured hippocampal neurons","volume":"60","author":"Wang","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0790","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1021\/ml3001616","article-title":"Substrate-Selective inhibition of cyclooxygenase-2: development and evaluation of achiral profen probes","volume":"3","author":"Windsor","year":"2012","journal-title":"Acs Med. Chem. Lett."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0795","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1016\/j.bmcl.2013.08.097","article-title":"Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib","volume":"23","author":"Windsor","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0800","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.14653","article-title":"p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus","volume":"5","author":"Xia","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0805","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.2174\/138161208784480144","article-title":"Cyclooxygenase-2 in synaptic signaling","volume":"14","author":"Yang","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0810","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pnpbp.2016.01.004","article-title":"Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors","volume":"67","author":"Yi","year":"2016","journal-title":"Progress in Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0815","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.tins.2015.08.001","article-title":"Depression as a microglial disease","volume":"38","author":"Yirmiya","year":"2015","journal-title":"Trends Neurosci."},{"issue":"-117","key":"10.1016\/j.neubiorev.2016.12.033_bib0820","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prostaglandins.2014.11.002","article-title":"Endocannabinoid metabolism by cytochrome P450 monooxygenases","volume":"116","author":"Zelasko","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0825","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hipo.22344","article-title":"Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity","volume":"25","author":"Zhang","year":"2015","journal-title":"Hippocampus"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0830","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.prostaglandins.2008.10.001","article-title":"Central prostaglandin D(2) exhibits anxiolytic-like activity via the DP(1) receptor in mice","volume":"88","author":"Zhao","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0835","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00213-013-3350-z","article-title":"Activation of postsynaptic 5-HT1A receptors improve stress adaptation","volume":"231","author":"Zhou","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0840","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-neuro-070815-014038","article-title":"Beyond the CB1 receptor: is cannabidiol the answer for disorders of motivation?","author":"Zlebnik","year":"2016","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0845","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0850","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol. (Oxford, Engl.)"},{"key":"10.1016\/j.neubiorev.2016.12.033_bib0855","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763416304699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763416304699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T23:36:57Z","timestamp":1750203417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763416304699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":171,"alternative-id":["S0149763416304699"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.12.033","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The endocannabinoid system as a target for novel anxiolytic drugs","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.12.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}